Prostate Cancer (Adenocarcinoma)Fase 2NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Talazoparib with enzalutamide, Talazoparib
49 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Próstata49 estudios
Prostate Cancer (Adenocarcinoma)Fase 2NCT06844383
Talazoparib with enzalutamide, Talazoparib
Advanced Prostate CancerFase 2NCT06369246
Stereotactic Body Radiation Therapy
Cáncer de próstataFase 2NCT07644598
Microboost SBRT, Whole gland de-escalation 30 Gy, Whole gland de-escalation 35 Gy
Metastatic Castration-Resistant Prostate CancerFase 2NCT06842498
FG-3246
Cáncer de próstataFase 2NCT04812366
Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab, Docetaxel
Prostate Cancer PatientsFase 2NCT07751159
Standard of Care HDR Brachytherapy, SBRT
Prostate AdenocarcinomaFase 2NCT05832086
Fasting Mimicking Diet (FMD), Standard Anti-Cancer Diet
Prostate AdenocarcinomaFase 2NCT07364071
Radiation therapy
Carcinoma de próstata resistente a la castraciónFase 2NCT06039371
Biopsy Procedure, Biospecimen Collection, Bone Scan, Carboplatin
Recurrent Castration-Sensitive Prostate CarcinomaFase 2NCT06378866Artículos
Abiraterone, Apalutamide, Biospecimen Collection, Bone Scan
Prostate AdenocarcinomaFase 2NCT06067269
Apalutamide, Biospecimen Collection, Computed Tomography, Gallium Ga 68 Gozetotide
Castration Resistant Metastatic Prostate CancerFase 2NCT04363164
Testosterone cypionate, Enzalutamide, Testosterone enanthate
Cáncer de próstataFase 2NCT05568550
Pembrolizumab, Olaparib, Androgen Deprivation Therapy, Radiation Therapy
Metastatic Castration-Resistant Prostate CarcinomaFase 2NCT06526299
Biospecimen Collection, Bone Scan, Computed Tomography, Lutetium Lu 177 Vipivotide Tetraxetan
Prostate AdenocarcinomaFase 2NCT04175431
Positron Emission Tomography, Lymphadenectomy, Radiation Therapy, Abiraterone Acetate
Cáncer de próstataFase 2NCT07313241
Prostate Fossa Radiotherapy, Pelvic nodal Radiotherapy, Androgen Deprivation Therapy (ADT)
Metastatic Castration-resistant Prostate CancerFase 2NCT06568562
XL092
Metastatic Castration-resistant Prostate CancerFase 2NCT06533644
Partial Oncolysis, SV-102
Prostate CarcinomaFase 2NCT04947254
Abiraterone Acetate, Antiandrogen Therapy, Apalutamide, Biopsy
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Fase 2NCT07216248
relugolix + ARPI, Intermittent- Relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix + ARPI.
Cáncer de próstataFase 2NCT07635238
MR-guided Stereotactic Body Radiation Therapy
Metastatic Castration-resistant Prostate CancerFase 2NCT06922318
ZEN-3694, Testosterone cypionate, Enzalutamide, Luteinizing hormone-releasing hormone (LHRH) analogue
Cáncer de próstataFase 2NCT05790213Artículos
Androgen Deprivation Therapy (ADT), Focal prostate ablation (focal therapy)
Cáncer de próstataFase 2NCT06392295
Para Aortic Radiation Therapy: Photon Therapy, Para Aortic Radiation Therapy: Proton Therapy, Androgen Deprivation Therapy, Androgen Receptor Signaling Inhibitor